Copyright Litigation

Published: 2 December 2014

The 2nd edition of Copyright Litigation: Jurisdictional Comparisons offers clear guidance for anyone considering litigation in a foreign country or involved in a multijurisdictional copyright litigation. Adopting a country-by-country approach, with a common format for each country, it enables quick and accurate comparisons between jurisdictions.

This title:

  • Covers the law and procedure in more than 25 major jurisdictions
  • Features contributions from leading local practitioners who are experts in the field
  • Offers a well organised starting point for international reference
  • Answers the key questions of multinational corporations and their legal advisors
  • Sets out each country’s courts and administrative system
  • Goes through civil court procedure
  • Explains the available remedies
  • Looks at the available enforcement options
  • Covers litigation costs
  • Uses a reader-friendly Q&A format that enables quick and easy cross-jurisdictional comparisons
  • Provides straightforward, practical commentary on each jurisdiction and the respective legal Systems

Related publications

SEE ALL

Insights

Insights – 04.08.2026

Switzerland steps up: Federal Patent Court affirms cross-border reach in patent litigation

Switzerland steps up: Federal Patent Court affirms cross-border reach in…

<p><strong>Switzerland as a forum for cross-border patent enforcement: the Federal Patent Court confirms its reach</strong></p> <p class="MsoBodyText">In a landmark decision of 17 July 2026 (S2025_003), the Swiss Federal Patent Court has sent a clear signal: Switzerland is very much in the game when it comes to cross-border patent enforcement. The Court confirmed that claims for infringement of foreign patent designations can be heard at the defendant’s Swiss domicile and established a powerful principle of parallel infringement analysis across all EPC member states. For patent holders pursuing multi-jurisdictional strategies, Switzerland must be on the map.</p> <p class="MsoBodyText">The case arose from interim proceedings brought by Regeneron Pharmaceuticals, Inc., Bayer HealthCare LLC and Bayer Consumer Care AG against Sandoz Group AG, Sandoz AG and Sandoz Pharmaceuticals AG. The claimants sought a pan-European injunction against the distribution of Sandoz’ aflibercept biosimilar, relying on both the Swiss designation and multiple foreign designations of a European patent. The case thus presented the Court with a textbook scenario for testing Switzerland’s credentials as a cross-border patent litigation forum.</p> <p class="MsoBodyText">The Court rose to the occasion, delivering clear guidance on two issues that matter for any cross-border patent strategy:</p>

Insights – 23.04.2026

Swiss Federal Supreme Court holds Swiss Russia sanctions are overriding mandatory law and can bar enforcement of arbitral awards

Swiss Federal Supreme Court holds Swiss Russia sanctions are overriding…

<p>In decision 4A_305/2025 of 13 March 2026, the Swiss Federal Supreme Court held that Swiss sanctions against Russia are overriding mandatory law and apply irrespective of the otherwise applicable law. The Court reasoned that the Swiss Ukraine Ordinance serves Switzerland’s core foreign-policy objectives and therefore applies as overriding mandatory law. In this case, the Court held that the sanctions barred enforcement of the award in Switzerland and treated the claim as unenforceable while the sanctions remain in force.</p>
SEE ALL
Lenz & Staehelin {PAGENO}/{nbpg}
{PAGENO}/{nbpg}